Jump to content
RemedySpot.com

Re: new recent side effects from ldn - night sweats with terrible nightmares!

Rate this topic


Guest guest

Recommended Posts

Guest guest

I also have night sweats but do not know if from LDN or hormones since

I'm 43. Had the night sweats before LDN but not as much. And when I

took the LDN later than 9pm, sweat mania and tossed and turned. Wonder

why the sweats happen.

Rhonda

> for the past week 1/2 been having ver very vivid dreams that

sometimes

> wake me up in terrible nightmares. also i am becoming " drenched " in

> night sweats, a symptom that does occur in CFS (which i use ldn for)

> itself, but ive never had before. i am going onto month 3 of LDN,

> switched to liquid only a few weeks ago.

>

> any ideas why this is?

Link to comment
Share on other sites

Guest guest

> for the past week 1/2 been having ver very vivid dreams that sometimes

> wake me up in terrible nightmares. also i am becoming " drenched " in

> night sweats, a symptom that does occur in CFS (which i use ldn for)

> itself, but ive never had before. i am going onto month 3 of LDN,

> switched to liquid only a few weeks ago.

>

> any ideas why this is?

===========

For those of you in the first 3 months of LDN therapy Dr. Bob Lawrence from the

UK who has MS & uses LDN himself explains why the temporary increase in MS

symptoms.

When starting this LDN(Low Dose Naltrexone) therapy in the treatment of MS,

there may also be some initial transient, though temporary, increase in MS

symptoms.

Experience in using this method has demonstrated most commonly, such as

disturbed sleep, occasionally with vivid, bizarre and disturbing dreams,

tiredness, fatigue, spasm and pain. These increased symptoms would not normally

be expected to last more than seven to ten days.

Rarely, other transient symptoms have included more severe pain and spasm,

headache, diarrhea or vomiting. These additional symptoms would appear to be

associated with the previous frequent use of strong analgesics, which

effectively create an addiction and dependency, thus increasing the body's

sensitivity to pain. This temporary increase in symptoms may also perhaps be

explained when we consider the manner in which this drug is expected to work.

Initially, MS occurs due to a reduction in the activity of the controlling

influence of the suppressor T-cells within the immune system. During an acute

relapse, the overall number of T-cells is reduced, the normal balance of helper

T-cells and suppressor T-cells is disrupted and the damaging helper (CD-4)

T-cells tend to predominate. This is the situation most pronounced during an

acute relapse but occurs similarly, but to a lesser extent, in chronic

progressive MS. Under the influence of LDN there will be an expected increase in

the overall numbers of T-cells but, because the CD-4, helper T-cells tend to

predominate at this time, an increase in their numbers will expectedly tend to

increase MS symptoms. It is only when the numbers of suppressor T-cells

effectively catch up that the normal balance is restored and symptoms once again

diminish and improve.

In addition, because LDN stimulates the immune system and many of the drugs

routinely used by the NHS in the treatment of MS further suppress the immune

system, LDN cannot be used in company with steroids, beta interferon,

methotrexate, azathioprine or mitozantrone or any other immune suppressant drug.

If there is any doubt, please submit a full list of the drugs you are presently

taking so that their compatibility may be assessed.

In addition, because LDN will also block the analgesic effects of any opiate

drugs (includes codeine, dihydrocodeine, morphine, pethidine or diamorphine)

presently being taken, the use of LDN will initially greatly increase the level

of pain experienced. It is therefore advisable that any opiate-like drugs be

discontinued at least two weeks before this treatment is initiated. When

starting the treatment it is essential that any untoward or adverse side-effects

are reported immediately so that the treatment process can be further assessed

and, if necessary, modified.

Dr. M R Lawrence

Link to comment
Share on other sites

Guest guest

Hi ,

The explanation by Dr. Bob Lawrence pertains to MS but is dealing with CFS. Does the same explanation hold true for those of us taking LDN and experiencing increased CFS and fibromyalgia symptoms?

Thanks

Barbara

[low dose naltrexone] Re: new recent side effects from ldn - night sweats with terrible nightmares!

> for the past week 1/2 been having ver very vivid dreams that sometimes > wake me up in terrible nightmares. also i am becoming "drenched" in > night sweats, a symptom that does occur in CFS (which i use ldn for) > itself, but ive never had before. i am going onto month 3 of LDN, > switched to liquid only a few weeks ago.> > any ideas why this is?===========For those of you in the first 3 months of LDN therapy Dr. Bob Lawrence from the UK who has MS & uses LDN himself explains why the temporary increase in MS symptoms.

When starting this LDN(Low Dose Naltrexone) therapy in the treatment of MS, there may also be some initial transient, though temporary, increase in MS symptoms. Experience in using this method has demonstrated most commonly, such as disturbed sleep, occasionally with vivid, bizarre and disturbing dreams, tiredness, fatigue, spasm and pain. These increased symptoms would not normally be expected to last more than seven to ten days.Rarely, other transient symptoms have included more severe pain and spasm, headache, diarrhea or vomiting. These additional symptoms would appear to be associated with the previous frequent use of strong analgesics, which effectively create an addiction and dependency, thus increasing the body's sensitivity to pain. This temporary increase in symptoms may also perhaps be explained when we consider the manner in which this drug is expected to work.Initially, MS occurs due to a reduction in the activity of the controlling influence of the suppressor T-cells within the immune system. During an acute relapse, the overall number of T-cells is reduced, the normal balance of helper T-cells and suppressor T-cells is disrupted and the damaging helper (CD-4) T-cells tend to predominate. This is the situation most pronounced during an acute relapse but occurs similarly, but to a lesser extent, in chronic progressive MS. Under the influence of LDN there will be an expected increase in the overall numbers of T-cells but, because the CD-4, helper T-cells tend to predominate at this time, an increase in their numbers will expectedly tend to increase MS symptoms. It is only when the numbers of suppressor T-cells effectively catch up that the normal balance is restored and symptoms once again diminish and improve. In addition, because LDN stimulates the immune system and many of the drugs routinely used by the NHS in the treatment of MS further suppress the immune system, LDN cannot be used in company with steroids, beta interferon, methotrexate, azathioprine or mitozantrone or any other immune suppressant drug. If there is any doubt, please submit a full list of the drugs you are presently taking so that their compatibility may be assessed. In addition, because LDN will also block the analgesic effects of any opiate drugs (includes codeine, dihydrocodeine, morphine, pethidine or diamorphine) presently being taken, the use of LDN will initially greatly increase the level of pain experienced. It is therefore advisable that any opiate-like drugs be discontinued at least two weeks before this treatment is initiated. When starting the treatment it is essential that any untoward or adverse side-effects are reported immediately so that the treatment process can be further assessed and, if necessary, modified. Dr. M R Lawrence

No virus found in this incoming message.Checked by AVG Anti-Virus.Version: 7.0.338 / Virus Database: 267.9.8/61 - Release Date: 8/1/05

No virus found in this outgoing message.

Checked by AVG Anti-Virus.

Version: 7.0.338 / Virus Database: 267.9.8/61 - Release Date: 8/1/05

Link to comment
Share on other sites

Guest guest

> Hi ,

>

> The explanation by Dr. Bob Lawrence pertains to MS but is dealing with

CFS. Does the same explanation hold true for those of us taking LDN and

experiencing increased CFS and fibromyalgia symptoms?

>

> Thanks

> Barbara

>

=========

I think yes. MS, CFS & Fibro are all autoimmune system diseases and are quite

closely related in many symptoms.

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...